| Product |
Schedules |
Booster |
Length of
protection |
Age range, yrs |
 |
| Meningococcal polysaccharide groups A, C, Y and W135 vaccine |
1 Dose |
High-risk
adults and children
over 5 yrs old:
every 5 yrs3
Children aged 2–5:
every 2–3 yrs3 |
At least 3 yrs |
2 yrs + |
 |
Paediatric
Hepatitis A (inactivated) and Hepatitis B (rDNA) vaccine (adsorbed) |
0, 6–12 months |
Hepatitis A not established but at least 10 yrs
Hepatitis B: not established
Need for booster should be drawn from monovalent vaccine experience
The Green Book: Hepatitis B vaccine booster ~5 yrs after primary immunisation |
Hepatitis A: at least 10 yrs
Hepatitis B: not established
Maintain protective anti-HBs antibody titre of ≥10 IU/l in immunocompromised
|
1–15 yrs |
 |
Adult
Hepatitis B vaccine |
0, 1, 6 months
0, 1, 2 & 12 months
0, 7, 21 days & 12 months (18 yrs+) (for exceptional circumstances)
0, 6 months (11–15 yrs) (where low risk during course)
|
Refer to Summary of Product Characteristics2
The Green Book: ~5 yrs after primary immunisation, once only, for those at continuing risk1 |
Maintain protective anti-HBs antibody titre of ≥10 IU/l in immunocompromised |
16 yrs + (11–15 yrs on 2 dose schedule) |
Paediatric
Hepatitis B vaccine |
0, 1, 6 months
0, 1, 2 & 12 months (more rapid response) |
Refer to Summary of Product Characteristics2
The Green Book: ~5 yrs after primary immunisation, once only, for those at continuing risk1 |
Maintain protective anti-HBs antibody titre of ≥10 IU/l in immunocompromised |
0–15 yrs |
 |
| Hepatitis A (antigen) vaccine |
1 Dose |
Booster
6–12 months for continuous
protection
Can boost up to 5 yrs after
1st dose |
1st dose –
at least 1 yr
Booster provides at least 25 yrs of protection in most people based upon predictive modelling |
16 yrs + |
 |
| Hepatitis A (antigen) vaccine |
1 Dose |
Booster
6–12 months for continuous
protection
Can boost up to 3 yrs after
1st dose |
1st dose –
at least 1 yr
Booster provides
at least
10 yrs of protection |
1–15 yrs |
 |
| Hepatitis A (inactivated) and Typhoid polysaccharide vaccine (adsorbed) |
1 Dose |
Hepatitis A
booster
6–12 months for continuous
protection
Not applicable for typhoid |
Booster provides at least 10 yrs Hepatitis A protection
Typhoid
revaccination
every 3 yrs
if at continued risk |
15 yrs + |
 Rotavirus vaccine |
For more information click on the product logo |
 |
Adult
Hepatitis A (inactivated) and Hepatitis B (rDNA) vaccine (adsorbed) |
0, 1, 6 months
0, 7, 21 days,
12 months
(18 yrs +)
(for exceptional circumstances) |
Hepatitis A: not established but antibodies persist for at least 10 yrs
Hepatitis B: not established
Need for booster should be drawn from monovalent vaccine experience
The Green Book: Hepatitis B Vaccine booster ~5 yrs after primary immunisation, once only, for those at continuing risk1 |
Hepatitis A: at least 10 yrs
Hepatitis B: not established
Maintain protective anti-HBs antibody titre of ≥10 IU/l in immunocompromised |
16 yrs + |
 |
Paediatric
Hepatitis A (inactivated) and Hepatitis B vaccine(rDNA) vaccine (adsorbed) |
0, 1, 6 months |
Hepatitis A: not established but antibodies persist for at least 10 yrs
Hepatitis B: not established
Need for booster should be drawn from monovalent vaccine experience
The Green Book: Hepatitis B Vaccine booster ~5 yrs after primary immunisation, once only, for those at continuing risk1 |
Hepatitis A: at least 10 yrs
Hepatitis B: not established
Maintain protective anti-HBs antibody titre of ≥10 IU/l in immunocompromised |
1–15 yrs |
 |
≥>
Typhoid polysaccharide vaccine |
1 Dose |
|
Up to 3 yrs
Revaccinate every 3 yrs if at continued risk |
2 yrs + |
 Varicella/chickenpox vaccine |
For more information click on the product logo |